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The Amaryllidaceae alkaloids are a family of amino acid derived alkaloids with many
biological activities; examples include haemanthamine, haemanthidine, galanthamine,
lycorine, and maritidine. Central to the biosynthesis of the majority of these
alkaloids is a C-C phenol-coupling reaction that can have para-para’, para-ortho’,
or ortho-para’ regiospecificity. Through comparative transcriptomics of Narcissus sp.
aff. pseudonarcissus, Galanthus sp., and Galanthus elwesii we have identified a
para-para’ C-C phenol coupling cytochrome P450, CYP96T1, capable of forming
the products (10bR,4aS)-noroxomaritidine and (10bS,4aR)-noroxomaritidine from
4′-O-methylnorbelladine. CYP96T1 was also shown to catalyzed formation of the
para-ortho’ phenol coupled product, N-demethylnarwedine, as less than 1% of the
total product. CYP96T1 co-expresses with the previously characterized norbelladine
4′-O-methyltransferase. The discovery of CYP96T1 is of special interest because it
catalyzes the first major branch in Amaryllidaceae alkaloid biosynthesis. CYP96T1 is also
the first phenol-coupling enzyme characterized from a monocot.
Keywords: cytochrome P450, secondary metabolism, transcriptomics, Amaryllidaceae alkaloids, phenol coupling
INTRODUCTION
The Amaryllidaceae alkaloids are produced by species of Amaryllidaceae including Narcissus
spp. (daffodil) and Galanthus spp. (snowdrop). Alkaloids from all major structural classes
of Amaryllidaceae alkaloids have biological activities. Some of these alkaloids have potential
pharmaceutical applications or are already established medicines. The alkaloid skeleton types,
haemanthamine, narciclasine, tazettine, and montanine are derived from the para-para’ C-C
phenol coupled, (10bR,4aS)-noroxomaritidine, biosynthetic precursor (Wildman and Bailey, 1969;
Fuganti et al., 1971; Feinstein and Wildman, 1976; see Figures 1, 2 for representative structures).
Specific examples of alkaloids derived from (10bR,4aS)-noroxomaritidine include haemanthamine,
maritidine, vittatine, and pretazettine. Haemanthamine has been shown to have antiproliferative
and apoptotic effects on cancer cell lines and antioxidant activity in a 2,2-diphenyl-1-picrylhydrazyl
scavenging assay (Oloyede et al., 2010; Van Goietsenoven et al., 2010; Havelek et al., 2014).
Crinine and its derivatives are also derived from a para-para’ C-C phenol coupling, however, the
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FIGURE 1 | Proposed biosynthetic pathways for representative Amaryllidaceae alkaloids directly derived from C-C phenol coupling. The previously
discovered NpN4OMT, the CYP96T1 discovered in this study, and potential enzyme classes involved in each step of the pathways are in blue.
phenol-coupled product is the enantiomer, (10bS,4aR)-
noroxomaritidine. Antibacterial activities have been noted for
the derivatives of the (10bS,4aR)-noroxomaritidine skeleton
including buphanidrine and distichamine (Cheesman et al.,
2012). An example of an ortho-para’ C-C phenol-coupling
product is lycorine, derived from noroxopluvine. Lycorine has
been documented to cause apoptosis in leukemia and multiple
myeloma cancer cell lines (Liu et al., 2004, 2009; Li et al., 2007).
Galanthamine is a representative derivative of the para-ortho’
C-C phenol-coupled product N-demethylnarwedine and is
used as an Alzheimer’s treatment drug (Wilcock et al., 2003).
It acts through acetylcholine esterase inhibition and nicotinic
receptor binding (Irwin and Smith, 1960; Barik et al., 2005). The
limited supply of some Amaryllidaceae alkaloids and diversity
of biological activities make the biosynthesis of Amaryllidaceae
alkaloids a topic of interest for biotechnology.
Haemanthamine is derived from the amino acids
phenylalanine and tyrosine. Phenylalanine was established
as a precursor by incorporation of [3-14C]phenylalanine into
haemanthamine in Nerine bowdenii (Wildman et al., 1962a).
The conversion of phenylalanine to 3,4-dihydroxybenzaldehyde
in haemanthamine biosynthesis was clarified by feeding [3-
14C]trans-cinnamic acid, [3-14C]para-hydroxycinnamic acid,
[7-14C]benzaldehyde, [7-14C]para-hydroxybenzaldehyde, [3H]
3,4-dihydroxybenzaldehyde, and [3H]threo-DL-phenylserine to
Narcissus pseudonarcissus. Incorporation into haemanthamine
from the precursors [3-14C]trans-cinnamic acid, [3-14C]para-
hydroxycinnamic acid, [3H]3,4-dihydroxybenzaldehyde, and
trace incorporation of [7-14C]para-hydroxybenzaldehyde, but
not other administered compounds, lead to the conclusion that
the pathway proceeds as follows: phenylalanine is converted to
trans-cinnamic acid, then to para-hydroxycinnamic acid, then to
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FIGURE 2 | Structures of relevant compounds.
3,4-dihydroxycinnamic acid or para-hydroxybenzaldehyde
followed by conversion to 3,4-dihydroxybenzaldehyde
(Suhadolnik et al., 1963). Observation of radiolabeled [3-
14C]tyrosine incorporation into haemanthamine established
tyrosine as a precursor (Jeffs, 1962). Tyrosine was demonstrated
to contribute to the 11 and 12 carbons of haemanthamine
by feeding [β-14C]tyrosine to Sprekelia formosissima and
[α-14C]tyrosine to Narcissus ‘Twink’ daffodil followed by
haemanthamine degradation experiments (Battersby et al.,
1961b; Wildman et al., 1962b; Figure 1). These results indicate
tyrosine also contributes carbons 1-4, 4a, and 10b because of
their ring shape and proximity to the 11 and 12 carbons of
haemanthamine. Equivalent sections of the galanthamine and
lycorine carbon skeleton also originate from tyrosine (Battersby
and Binks, 1960; Barton et al., 1963). Tyrosine is converted
into tyramine by tyrosine decarboxylase, a well characterized
enzyme in other secondary metabolite pathways (Lehmann and
Pollmann, 2009).
3,4-Dihydroxybenzaldehyde and tyramine are condensed to
a Schiff-base and reduced to norbelladine. The central role
of norbelladine in Amaryllidaceae alkaloid biosynthesis was
demonstrated by incorporation of [1-14C]norbelladine into
haemanthamine, lycorine, and galanthamine (Barton et al.,
1961, 1963; Battersby et al., 1961a,b). Next, norbelladine is
methylated to 4′-O-methylnorbelladine. In 1963, crude enzyme
extracts of N. bowdenii were used to perform a preliminary
characterization of the 4′-O-methyltransferase conducting this
methylation (Mann, 1963). This cation-dependent norbelladine
4′-O-methyltransferase (N4OMT) was identified in Narcissus
sp. aff. pseudonarcissus, and enzymatically characterized by
heterologous expression in E. coli (Kilgore et al., 2014).
(10bR,4aS)-Noroxomaritidine is formed from the para-para’ C-
C phenol coupling of 4′-O-methylnorbelladine. The biosynthesis
of haemanthamine deviates from alkaloids with ortho-para’ and
para-ortho’ carbon skeletons at this branch point. The next step
is thought to be a reduction of the ketone group to synthesize
8-O-demethylmaritidine followed by an oxide bridge formation
to form vittatine. Conversion of vittatine to haemanthamine is
thought to occur through hydroxylation followed by methylation
(Figure 1). The conversion of vittatine to haemanthamine has
been demonstrated by radiolabeling studies. The order of
hydroxylation and methylation in this conversion is inferred
from the presence of the hydroxylated 11-hydroxyvittatine
in the N. bowdenii plants under investigation and the
absence of the methylated (10bR,4aS)-buphanisine (Feinstein
and Wildman, 1976). Haemanthamine accumulates in planta
and is modified further to compounds such as haemanthidine
and pretazettine in some Amaryllidaceae. The proposed
biosynthesis of galanthamine from the ortho-para’ product
N-demethylnarwedine through the reduced intermediate N-
demethylgalanthamine has been reviewed recently (Eichhorn
et al., 1998; Kilgore et al., 2014).
Cytochrome P450 enzymes are a diverse enzyme family
with numerous functions. Reactions catalyzed include
hydroxylation, C-C and C-O phenol coupling, oxide bridge
formation, carbon-carbon bond cleavage, demethylation, and
rearrangements of carbon skeletons (Mizutani and Sato, 2011).
Previously documented C-C phenol coupling by cytochrome
P450 enzymes that synthesize salutaridine (CYP719A1), (S)-
corytuberine (CYP80G2), and cyclodipeptide cyclo(l-Tyr-l-Tyr)
(CYP121), suggest the C-C phenol coupling reactions found
in Amaryllidaceae alkaloid biosynthesis are cytochrome P450
dependent (Ikezawa et al., 2008; Belin et al., 2009; Gesell et al.,
2009).C-C phenol coupling reactions have also been documented
in the human cytochrome P450s CYP2D6 and CYP3A4 with
the substrate (R)-reticuline (Grobe et al., 2009). In addition to
cytochrome P450s peroxidases and laccases are documented
phenol-coupling enzymes (Schlauer et al., 1998; Davin et al.,
2008; Constantin et al., 2012).
Orphan plant species are frequently of interest due to their
unique metabolism. Study of this metabolism is problematic
due to scarcity of genetic information, limited mutant libraries,
and lack of efficient transformation methods. In addition,
secondarymetabolites can be phylogenetically restricted. Method
development for efficient metabolic pathway elucidation in
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orphan species is therefore desirable. An efficient work-flow
for the identification of biosynthetic genes has been previously
developed and applied to Amaryllidaceae alkaloid biosynthesis.
Methyltransferase transcripts correlating with galanthamine
accumulation in N. sp. aff. pseudonarcissus were targeted and
tested for norbelladine 4′-O-methyltransferase activity, leading to
the discovery of the biosynthetic gene N4OMT (Kilgore et al.,
2014). In this study, a similar work-flow is applied utilizing
transcriptomic data frommultiple species to identify cytochrome
P450 genes that co-express withN4OMT. This led to the isolation
and characterization of CYP96T1, which catalyzes formation of
the para-para’ and a small quantity of the para-ortho’ C-C phenol
couple with 4′-O-methylnorbelladine.
MATERIAL AND METHODS
Plant Tissue and Chemicals
Leaf, bulb, and inflorescence tissues were collected from adult
blooming N. sp. aff. pseudonarcissus and Galanthus sp. plants
in St. Louis, MO and Galanthus elwesii in Pullman, WA.
Chemicals acquired from Sigma Aldrich include ammonium
acetate 97% A.C.S. reagent, HPLC grade ethanol, catalase from
bovine liver, and tyramine 99%. Other chemicals purchased
include ammonium acetate extra pure 25% solution in water
and hydrogen peroxide 35 wt % solution in water from Acros
Organics, ampicillin from GoldBio, and vanillin from Merck.
Several compounds were obtained from our natural product
collection including: veratraldehyde (can be acquired from
Sigma), norbelladine, 4′-O-methylnorbelladine, (R)-coclaurine,
and (S)-coclaurine (Battersby et al., 1964; Teitel and Brossi,
1968; Park, 2014; Ruiz-Olalla et al., 2015). Haemanthamine was
previously isolated from Narcissus pseudonarcissus. Additional
materials are as described previously (Gesell et al., 2009; Kilgore
et al., 2014). Plant alkaloids were extracted with 70% ethanol as
previously described (Kilgore et al., 2014).
Transcriptome Assembly and Transcript
Abundance Estimation
The transcriptomes assembled using ABySS and MIRA for
Galanthus sp. and G. elwesii were assembled in the same
manner as the previously described ABySS and MIRA N.
sp. aff. pseudonarcissus transcriptome (Kilgore et al., 2014),
but with 50 base paired-end reads with leaf, bulb, and
inflorescence tissues. Alternative transcriptomes were made
using Trinity. For these transcriptomes the same raw reads
were assessed using FastQC followed by trimming with the
FASTX tool kit1. The fastx_trimmer was used to remove the
first 13 bases and fastq_quality_trimmer was used to remove
all bases on the 3′ end with a Phred quality score lower
than 28. Sequences below 30 bases or without a corresponding
paired-end read were removed from the trimmed data set.
Cleaned reads were input into the Trinity pipeline with default
parameters for each data set (Haas et al., 2013). The unprocessed
reads and Trinity assemblies were used with the Trinity tool
1“FASTX-Toolkit website.” Available online at: http://hannonlab.cshl.edu/fastx_
toolkit (Accessed Jul 2, 2014).
RNA-Seq by Expectation-Maximization (RSEM) to obtain the
transcripts per million mapped reads (TPM) for all transcripts
in each tissue (leaf, bulb, and inflorescence) for each Trinity
assembly. To assess quality, the following parameters were
considered: the size of the resulting assembly and identification
of homologs to the conserved genes Zea mays MADS6
(NP_001105153.1), Arabidopsis thaliana ribulose bisphosphate
carboxylase small chain 1A (NP_176880.1), and the Oryza sativa
ribulose-1,5-bisphosphate carboxylase/oxygenase large subunit
(AAB02583.1). Assemblies and transcript expression data are
deposited in the MedPlant RNA Seq Database, http://www.
medplantrnaseq.org. ESTScan trained against A. thaliana open
reading frames was used to predict peptides encoded in all Trinity
assemblies (Iseli et al., 1999).
Candidate Gene Identification
BLASTP with an e-value cut off of 1 × 10−4 was used to
find homologs to known cytochrome P450 enzymes in all
transcriptomes. A list of 472 unique, curated plant cytochrome
P450 sequences from Dr. David Nelson, University of Tennessee,
was used as a query against the ESTScan predicted peptides for
each assembly (SupplementaryMaterial 1). HAYSTACKwas used
to find transcripts co-expressing with N4OMT in each assembly
(see Table 1 for N4OMT expression). All Galanthus N4OMT
expression estimates were for the closest NpN4OMT1 homolog
in the assembly being used. N. sp. aff. pseudonarcissus N4OMT
expression was based on the RT-PCR data for NpN4OMT1
expression obtained previously (Kilgore et al., 2014). HAYSTACK
parameters are as follows: correlation cutoff ≥ 0.8, background
cutoff ≥ 1, fold cutoff ≥ 4, and p-value cutoff ≤ 0.05 (Mockler
et al., 2007). Homologs to the N. sp. aff. pseudonarcissus
cytochrome P450s co-expressing with N4OMT were identified
using BLASTNwith an e-value cut off of 1×10−50 queried against
the transcripts co-expressing with N4OMT in the Galanthus spp.
assemblies. For each N. sp. aff. pseudonarcissus cytochrome P450
candidate, the total number of assemblies with an N4OMT co-
expressing BLASTN hit were determined. Candidates present in
TABLE 1 | Models used in HAYSTACK analysis.
Model name Leaf Inflorescence Bulb
NN. sp. aff. pseudonarcissus N4OMT
(relative units)
1 30 45
NGalanthus sp. N4OMT (RPM) 0.01 33.3 140
NGalanthus elwesii N4OMT (RPM) 2.24 22.6 71.7
TCN. sp. aff. pseudonarcissus N4OMT
(TPM)
NA NA NA
TGalanthus sp. N4OMT (TPM) 2.42 29.0 94.7
TGalanthus elwesii N4OMT (TPM) 16.0 49.3 202
N. sp. aff pseudonarcissus galanthamine
(µg/g)*
196 126 1070
Galanthus sp. galanthamine (µg/g) 0.0516 0.102 0.223
Galanthus elwesii galanthamine (µg/g) 1.05 0.759 1.39
NAbySS and MIRA assembly; Chomolog not found; TTrinity assembly; RPM, reads per
million; NA, not applicable; *previously published in Kilgore et al. (2014).
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five of the five N4OMT co-expressing lists were considered top
priority candidate genes and were cloned (Figure 3).
Polymerase Chain Reaction (PCR) and
Cloning
For cloning CYP96T1, designated as narcissus-20101112|22907
in the ABySS and MIRA N. sp. aff. pseudonarcissus assembly,
a close homolog of CYP96T1 with the designation narcissus-
20101112|13079 was identified with a complete ORF. Primers
were based on the 5′ sequence of narcissus-20101112|13079
and the 3′ sequence of CYP96T1. Design of inner primers was
validated by sequencing (GENEWIZ Inc.) of the outer PCR
product using the following primers CYP96T forward outer (5′-
ACATCCCCCCCAAAAAAATCATAAC-3′), CYP96T reverse
outer (5′-AGACCATCAATGTGATCACCA-3′), and CYP96T
reverse sequencing (5′-TGGTGAAATCGTTGAATTGGTTGT-
3′). N. sp. aff. pseudonarcissus bulb cDNA was prepared as
previously described (25). The outer PCR reaction contained
0.2µM each of CYP96T forward outer and CYP96T reverse
outer primers, 1µl of bulb cDNA, 1X Phusion HF reaction
buffer, 0.3mM dNTPs, and 1 U NEB Phusion High-Fidelity
DNA Polymerase in a 50µl reaction. The PCR program
parameters were as follows: 30 s 98◦C 1 cycle, 15 s 98◦C,
30 s 52◦C, 2min 72◦C 35 cycles, and 5min 72◦C 1 cycle.
Inner PCR parameters were identical except primers used
were CYP96T forward inner (5′-aattGCGGCCGCATGGCCACT
TCTTCTTCAGCA-3′) and CYP96T reverse inner (5′-aatt
TCTAGATCACATGACTGATCTCTTTCT-3′) adding NotI and
XbaI restriction sites, respectively (underlined), the outer PCR
reaction was added as template as opposed to cDNA, and the PCR
cycles were reduced to 25.
FIGURE 3 | Work-flow for identification of candidate cytochrome P450 enzymes. Following the generation of transcriptome assemblies, cytochrome P450
enzymes were identified with BLASTP (Navy blue) and genes correlating with N4OMT were identified with HAYSTACK (Red). The genes present in both lists makeup
the initial candidate gene list (Green). Homologs of these genes were identified in the N4OMT correlating lists of the other transcriptomes using BLASTN (Gray).
Candidates with homologs in all five N4OMT correlating lists were cloned from N. sp. aff. pseudonarcissus, Narcissus sp. (light blue). The analysis for the N. sp. aff.
pseudonarcissus ABySS and MIRA assembly is completely diagrammed to illustrate the process followed in every assembly. The number of transcripts selected in
each step is in parentheses. The N. sp. aff. pseudonarcissus Trinity assembly is excluded from this work-flow due to its poor quality.
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The inner PCR product and pVL1392 vector were digested
with NEB NotI and XbaI followed by PCR purification with
the QIAquick PCR Purification Kit and ligation with NEB
T4 DNA ligase according to manufacturer’s instructions. The
resulting construct was transformed into DH5α E. coli chemically
competent cells. Recombinant bacteria were selected on Luria-
Bertani 1.5% agar plates with 50µg/ml ampicillin.
Transformants were screened by colony PCR with the
following components: 0.67µM polyhedrin forward (5′-
AAAATGATAACCATCTCGC-3′) and polyhedrin reverse
(5′-GTCCAAGTTTCCCTGTAGA-3′) primers, ThermoPol
Reaction buffer 1X, 0.2mM dNTPs, and 1 U of NEB Taq DNA
polymerase in a volume of 20µl. The PCR parameters were as
previously described (Kilgore et al., 2014). Plasmid minipreps
of 5ml cultures in LB supplemented with 50µg/ml ampicillin
were prepared using the QIAGEN QIAprep Spin Miniprep
Kit according to manufacturer’s instructions and sequenced
with polyhedrin forward and reverse primers by Eurofins
genomics. All reproducible sequences were named by Dr. David
Nelson, University of Tennessee. These names were CYP96T1,
CYP96T2, and CYP96T3 with the GenBank accession numbers
KT693311, KT693312, and KT693313, respectively. The closest
biochemically characterized homolog to the resulting CYP96T1
clone, CYP96A15, was identified in the UniProt database with
BLASTP. CYP96T1, CYP96T2, CYP96T3, the original CYP96T1
sequence, and CYP96A15 were aligned with MUSCLE in the
CLC main workbench version 6.9.1 (Edgar, 2004).
Protein Expression
Co-transfection of CYP96T1 in pVL1392 and Baculogold
baculoviurus (BD Biosciences), viral amplification, protein
expression, and microsome preparation in Spodoptera frugiperda
Sf9 cells was performed as previously described (Gesell et al.,
2009). Microsomes of Sf9 cells expressing CYP96T1 were
solubilized with 0.17% emulgen 913 at 4◦C for 15min followed
by centrifugation (15,000 × g for 15min) before obtaining the
CO difference spectra. The resulting CYP96T1 concentration
was used to calculate concentration of CYP96T1 in all
subsequent Sf9 cell cultures. CYP96T1 was always co-expressed
with Eschscholzia californica cytochrome P450 reductase (CPR)
(Gesell et al., 2009). For a negative control CPR was expressed
without CYP96T1.
3′-O-Methylnorbelladine and
3′,4′-O-Dimethylnorbelladine Synthesis
For the synthesis of 3′-O-methylnorbelladine sodium
cyanoborohydride (50mM), vanillin (5mM), and tyramine
(5mM) were mixed in 2.5ml anhydrous methanol for
2 days at room temperature. For synthesis of 3′,4′-O-
dimethylnorbelladine, sodium cyanoborohydride (50mM),
veratraldehyde (5mM), and tyramine (5mM) were mixed in
2.5ml anhydrous methanol for 2 days at room temperature.
The reaction mix was then taken to dryness under N2. The
resulting material was suspended in 200µl of 1M NaCO3 pH
9.5 and extracted twice with 400µl of ethyl acetate by vortexing
for 1min, followed by centrifugation at 16,100 × g for 2min at
room temperature. Ethyl acetate extractions were pooled and
dried under vacuum. Extractions were re-suspended in 10%
acetonitrile and 0.1% formic acid and purified by fractionation
using a Waters fraction collector III and Waters 1525 binary
HPLC pump as previously described (Kilgore et al., 2014).
3′-O-methylnorbelladine was collected at 9min for ∼1min and
3′,4′-O-dimethylnorbelladine at 11.5min for ∼1min. Purified
compound was dried under vacuum, re-suspended in H2O and
quantified with a 4′-O-methylnorbelladine standard curve using
peak area by HPLC with the method stated above.
Enzyme Assays
Screening assays contained 30mM KPO4 pH 8.0, 1.25mM
NADPH, 10µM substrate, and 70µl of virus infected Sf9
cell suspension in 200µl total volume. The assays were
incubated for 2–4 hr at 30◦C. 4′-O-metylnorbelladine was
tested for all CYP96T variants. CYP96T1 was used for substrate
specificity tests on norbelladine, N-methylnorbelladine, 4′-
O-methyl-N-methylnorbelladine, 3′-O-methylnorbelladine,
3′,4′-O-dimethylnorbelladine, haemanthamine, (S)-coclaurine,
(R)-coclaurine, and mixed (10bS,4aR)- and (10bR,4aS)-
noroxomaritidine (see Figures 1, 2 for chemical structures).
Assays derivatized with sodium borohydride were incubated 2
hr at 30◦C followed by addition of 0.5 volumes 0.5M sodium
borohydride in 0.5M sodium hydroxide and incubated 30min
at RT. The CYP96T1 assay resolved on a Chiral-CBH column
and assays measured with HPLC used fresh CYP96T1 and
CPR expressing Sf9 cell protein prepared using re-amplified
virus. Kinetic assays were run in the linear time range for each
substrate in 200mM KPO4 pH 6.5 buffer with 40µl assays.
Assays testing the effects of added H2O2 (0.1%) and/or catalase
(0.1mg/ml) were done for 20min at 30◦C with 10µM 4′-O-
methylnorbelladine, 1mM NADPH, and 200mM KPO4 pH 6.5
buffer. Product for overnight enzyme assays of (R)-coclaurine,
(S)-coclaurine, and 4′-O-methyl-N-methylnorbelladine were
quantified at 277 nm against a noroxomaritidine standard
curve with the same HPLC method and setup used for 3′-O-
methylnorbelladine and 3′,4′-O-dimethylnorbelladine isolation.
These products were subsequently used as standards for
quantifying kinetic assays. Km and kcat values were estimated
using R version 3.2.0 with nonlinear fitting.
LC-MS/MS
Enzyme assays on all substrates were extracted as previously
described and run on a QTRAP 4000 coupled to a IL-
20AC XR prominence liquid auto sampler, 20AD XR
prominence liquid chromatograph and Phenomenex Luna
5µm C8(2) 250 × 4.60mm column. HPLC gradient and MS
settings were as previously described (Kilgore et al., 2014).
Assay specific MS/MS parameters are presented in Table 2.
Multiple Reaction Monitoring (MRM) parameters for relative
quantification of (10bS,4aR)- and (10bR,4aS)-noroxomaritidine,
N-demethylnarwedine, narwedine, and the two unknown
compounds are presented in Table 3. For analysis of product
chirality, a Chrom Tech, Inc. Chiral-CBH 100 × 4.0mm, 5µM
column was used with a 30min isocratic flow of 2.5% HPLC
grade ethanol and 10mM ammonium acetate with pH adjusted
to 7.0 with ammonium hydroxide. Kinetic assays were quantified
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TABLE 2 | MS/MS parameters for substrate tests.
Substrate Product specific parameters (Collision
energy) (Declustering potential) (First
quadrupole m/z)
Substrate specific parameters
(Collision energy) (Declustering
potential) (First quadrupole m/z)
4′-O-Methylnorbelladine (35)(70)(272.30) (20)(60)(274.30)
4′-O-Methyl-N-methylnorbelladine (35)(70)(286.20) (20)(60)(288.30)
3′-O-Methylnorbelladine (35)(70)(272.30) (35)(60)(274.30)
3′,4′-O-Dimethylnorbelladine (35)(70)(286.20) (20)(60)(288.30)
Norbelladine (35)(60)(258.00) (15)(50)(260.00)
N-Methylnorbelladine (35)(70)(272.30) (20)(60)(274.30)
Haemanthamine (35)(70)(300.12)/(35)(70) (318.13)HO (35)(70)(302.14)
(10bS,4aR)- and (10bR,4aS)-Noroxomaritidine (35)(70)(270.30)/(35)(70) (288.30)HO (35)(70)(272.30)
Isovanillin and tyramine (20)(40)(290.30)a/(20)(60)(272.20)b/(35)(70)(270.20)c (20)(60)(138.20)/(20)(50)(153.20)
(S)-Coclaurine (35)(70)(284.30)/(30)(60) (570.60)dim (20)(70)(286.30)
(R)-Coclaurine (35)(70)(284.30)/(30)(60) (570.60)dim (20)(70)(286.30)
4′-O-Methylnorbelladine assays followed by sodium borohydride
derivatization
(20)(60)(274.30) (20)(60)(274.30)
HOhydroxylation monitored; dimdimer formation monitored; aC-C phenol coupling with no amine aldehyde condensation; bamine aldehyde condensation/amine aldehyde condensation
with C-C phenol coupling and a reduction; camine aldehyde condensation with C-C phenol coupling.
TABLE 3 | MS/MS parameters used in MRM studies.
Compound (C-C phenol coupling
type)
MRM parameters (Collision energy)
(Declustering potential) (First
quadrupole m/z) (Second quadrupole
m/z) (Retention time min)
Noroxomaritidine(para’-para) (35)(70)(272.3)(229.0)(5.3)
N-Demethylnarwedine(para’-ortho) (35)(70)(272.3)(201.0)(7.9)
4′-O-Methyl-N-methylnorbelladine
assay unknown 1(potential para’-para
product)
(35)(70)(286.1)(271.0)(4.7)
4′-O-Methyl-N-methylnorbelladine
assay unknown 2 (potential
ortho’-para product)
(30)(70)(286.1)(243.0)(7.5)
Narwedine(para’-ortho) (30)(70)(286.1)(229.1)(8.1)
with an isocratic flow 20% acetonitrile and 0.08% formic acid
with the Phenomenex Luna 5µm C8(2) 250 × 4.60mm column
connected to the same QTRAP 4000 setup. MRM transitions
used in kinetics and H2O2/catalase assays were 284.1/223.0 m/z
for the (S)-coclaurine and (R)-coclaurine products, 286.1/271.0
m/z for the 4′-O-methyl-N-methylnorbelladine para-para’
product, and 272.3/229.0m/z for noroxomaritidine.
Quantification of galanthamine and haemanthamine found
in N. sp. aff. pseudonarcissus bulb scales was performed with
a QTRAP 6500, the Phenomenex Luna 5µm C8(2) 250 ×
4.60mm column, and an isocratic flow method 0.8ml/min
0.08% formic acid and 20% acetonitrile. The MRM transitions
used for galanthamine were m/z 288.1/270.0 collision energy
30 and declustering potential 70; m/z 288.1/213.1 collision
energy 30 and declustering potential 70. For haemanthamine, the
MRM transitions were m/z 302.1/270.1 collision energy 30 and
declustering potential 70;m/z 302.1/252.1 collision energy 30 and
declustering potential 70.
RESULTS
Transcriptome Assembly and Transcript
Abundance Estimation
Key statistics for each transcriptome including total number of
transcripts, maximum transcript length, and average transcript
length are summarized in Table 4. ABySS and MIRA assemblies
were found to have a high number of incomplete ORFs. This was
problematic for cloning and highlighted the potential problem of
unannotated transcripts and inaccurate expression estimates in
transcripts with short assemblies. Quality processed reads were
reassembled with Trinity to provide alternate information on the
same transcripts. These assemblies provided additional sequence
information with comparable expression estimates. The N. sp.
aff. pseudonarcissus Trinity assembly resulted in a large number
of contigs but lacked well-characterized genes, such as ribulose
bisphosphate carboxylase small chain 1A and NpN4OMT1. In
addition, the maximum contig length was 40,450, well above
the expected size range. For these reasons, further analysis of
the N. sp. aff. pseudonarcissus Trinity assembly was abandoned.
The other assemblies have comparable statistics regardless of
assembly method. Because these assemblies are complementary
to each other, both sets of Galanthus assembles were used for
subsequent analysis (Table 4).
Candidate Gene Identification and Cloning
The pattern-matching algorithm HAYSTACK was used to
identify transcripts that co-express with N4OMT. N4OMT is
the only validated gene involved in Amaryllidaceae alkaloid
biosynthesis to date. It is positioned in the pathway just prior
to the C-C phenol-coupling step and co-accumulates with
the Amaryllidaceae alkaloid galanthamine across Narcissus and
Galanthus species (Table 1). Therefore, N4OMT gene expression
is a suitable choice to serve as a model for analysis of
co-expressing transcripts encoding additional Amaryllidaceae
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TABLE 4 | Transcriptome statistics.
N. sp. aff.
pseudonarcissus AbySS
and MIRA*!
Galanthus sp.
AbySS and
MIRA*
Galanthus
elwesii AbySS
and MIRA*
N. sp. aff.
pseudonarcissus
Trinity#
Galanthus sp.
Trinity#
Galanthus
elwesii Trinity#
Sequences (number of
sequences)
106,450 143,394 224,205 608,439 103,471 97,789
Longest (bp) 13,381 15,365 19,356 40,450 13,629 13,055
N50 (bp) 1130 1418 1330 931 1044 1139
Mean (bp) 551 664 602 671 723 777
Median (bp) 248 271 245 430 481 528
*Assemblies were set to have a minimum cut off of 100 bp; #assemblies were set to have a minimum cut off of 201 bp; !assembly previously reported in Kilgore et al. (2014).
alkaloid biosynthetic genes. Since the C-C phenol-coupling
enzyme is targeted herein, BLASTP was used to find transcripts
that encode putative cytochrome P450 enzymes. The resulting
544 N. sp. aff. pseudonarcissus cytochrome P450 protein
sequences were compared to the list of 3,704 N4OMT co-
expressing transcripts identified by HAYSTACK. This resulted
in the identification of 18 N4OMT co-expressing cytochrome
P450 transcripts in theN. sp. aff. pseudonarcissus assembly. These
transcripts were shown by BLASTP to be closely homologous
to a diversity of cytochrome P450 families including CYP71,
72 73, 81, 86, 88, 90, 94, 95, and 704 (Table S1). One of
the CYP86 candidates was re-annotated as a CYP96 after
a closer examination of the full sequence and placed in a
novel cytochrome P450 subfamily, CYP96T, by Dr. David
Nelson, University of Tennessee. The Galanthus assemblies were
interrogated using these 18 sequences to identify close homologs.
This allowed for selection of the cytochrome P450 transcripts
that consistently co-expressed with N4OMT across species in
all assemblies. One candidate, (CYP96T1) co-expressed with
N4OMT in all assemblies and was investigated further in N.
sp. aff. pseudonarcissus where its correlation was 0.9995. A
close homolog to CYP96T1 with 99% identity in shared ORF
sequence and the first 67 bases of the 3′ UTR was identified. In
contrast to CYP96T1, this transcript was complete at the 5′ end
of the ORF and contained 5′ UTR sequence information. This
allowed the incomplete 5′ region of CYP96T1 to be predicted
by comparison. The PCR product generated with outer primers
was sequenced and the inner primer sequences were found not
to deviate from the assembly prediction. A clone was acquired
with no conflicts to the previously known CYP96T1 sequence
and was used for functional characterization. Two additional
variants were cloned reproducibly. The closest biochemically
characterized homolog to CYP96T1 was CYP96A15 from A.
thaliana (Q9FVS9) (Figure 4).
Enzyme Assays and Analysis by LC-MS/MS
The concentration of CYP96T1 in Sf9 cell culture was determined
to be 2.5 nM by CO-difference spectra. The temperature and pH
optima for 4′-O-methylnorbelladine substrate were determined
to be 30◦C (half height ±5 − 10◦C) and 6.5 (half height ±1),
respectively. Testing of the CYP96T1 enzyme demonstrated
that several structurally related alkaloids were C-C phenol
coupled as detected by LC-MS/MS. These reactions were
accompanied by a background reaction catalyzed by the
Sf9 cells. 4′-O-methylnorbelladine was C-C phenol coupled
into N-demethylnarwedine, (10bS,4aR)- and (10bR,4aS)-
noroxomaritidine in CYP96T1 assays. (10bS,4aR)- and
(10bR,4aS)-noroxomaritidine were identified by their identical
liquid chromatographic retention times (Figure 5A) and mass
spectrometric fragmentation pattern with (10bS,4aR)- and
(10bR,4aS)-noroxomaritidine mixed standard (Figures 5C,D).
To determine the chirality of the noroxomaritidine product,
4′-O-methylnorbelladine assays with CYP96T1 were analyzed
with a chiral-CBH column by LC-MS/MS. Chromatographic
separation of (10bS,4aR)- and (10bR,4aS)-noroxomaritidine
standards was achieved preceding MS/MS analysis. Equal
amounts of each enantiomer were observed (Figure 6A). A
mass spectrometric comparison of standards (Figures 6B,C)
and enzymatically formed (10bS,4aR)- and (10bR,4aS)-
noroxomaritidine (Figures 6D,E) yielded identical MS/MS
fragmentation patterns. The enzyme is, therefore, producing
both (10bS,4aR)- and (10bR,4aS)-noroxomaritidine. A minor
N-demethylnarwedine product was also detected in assays
analyzed by HPLC on the Luna C8 column. The relative
quantity of (10bS,4aR)- and (10bR,4aS)-noroxomaritidine and
N-demethylnarwedine formed in assays with CYP96T1 are
quantified in Figures 7A,B. HPLC was used to measure the
relative contribution of these compounds to total product.
(10bS,4aR)- and (10bR,4aS)-noroxomaritidine account for
∼99% of the total product in CYP96T1 assays. (10bS,4aR)-
and/or (10bR,4aS)-noroxomaritidine and N-demethylnarwedine
are also produced in assays containing only Sf9 cells and
4′-O-methylnorbelladine, but not in an enzyme-free control,
indicating Sf9 cells have the ability to catalyze the C-C phenol
couple with 4′-O-methylnorbelladine (Figure 5A). In addition,
the N-methylated form of 4′-O-methylnorbelladine, 4′-O-
methyl-N-methylnorbelladine, was shown to produce several
C-C phenol-coupled products when assayed with Sf9 cells alone,
as indicated by the detection of products with a mass reduction
of 2 m/z, including narwedine and two unknown products
(Figures 5B, 7D). Unknown 1 is enzymatically produced from
4′-O-methyl-N-methylnorbelladine by CYP96T1, as indicated
by the increase of product in assays containing CYP96T1 as
compared to the CPR-only control (Figure 5B). Unknown 2
production can be explained by the endogenous activity of
Sf9 cells only expressing CPR on 4′-O-methylnorbelladine
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FIGURE 4 | MUSCLE alignment of protein sequences. The sequences include CYP96T1, CYP96T2, CYP96T3, the CYP96T1 from the N. sp. aff.
pseudonarcissus ABySS and MIRA assembly, and CYP96A15 from A. thaliana (Q9FVS9). Simplified consensus motifs for cytochrome P450 enzymes are placed
above the corresponding color inverted CYP96T1 sequence. Dots are exact matches to CYP96T1 and dashes are gaps.
(Figure 7E). These observations were confirmed by an MRM-
based relative quantification of selected transitions of these three
products (Figures 7C–E). The LC-MS/MS fragmentation pattern
of unknown 1 is a mixture of masses found in the para’-para
products (10bS,4aR)- and (10bR,4aS)-noroxomaritidine (165.1
m/z, 184.2 m/z, 195.0 m/z, 212.2 m/z, 229.0 m/z) and masses
+14 m/z (120.1 m/z, 149.1 m/z, 243.2 m/z, 258.1 m/z, 271.0
m/z), representing the addition of a methyl moiety (Figure 5E).
For this reason, it appears the enzyme is capable of catalyzing
formation of the para-para’ C-C phenol-couple regardless of
N-methylation state (Figures 7A,C). To examine the ability
of CYP96T1 to C-C phenol couple substrates with an altered
carbon linker between the phenol groups, (S)-coclaurine, and
(R)-coclaurine were also tested. Assays on ether (S)-coclaurine
or (R)-coclaurine yield products with a mass −2m/z, which is
consistent with a C-C phenol coupling. Product formation is
not observed when norbelladine or N-methylnorbelladine is
used as substrate. These results indicate the 4′-O-methylation
state of norbelladine may be important for substrate-enzyme
binding. The substrates 3′-O-methylnorbelladine and 3′,4′-O-
dimethylnorbelladine were tested to determine the relevance of
3′-O-methylation; products were not detected (Table 5).
The Km of (S)-coclaurine, 636.7µM, and (R)-coclaurine,
658.8µM, are several orders of magnitude higher than the Km
values for 4′-O-methylnorbelladine, 1.13, and 4′-O-methyl-
N-methylnorbelladine, 3.28 (Table 5). Substrate inhibition
was observed in 4′-O-methylnorbelladine and 4′-O-methyl-N-
methylnorbelladine with Ki values of 64.34 ± 26.36µM and
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FIGURE 5 | LC-MS/MS enhanced product ion scan (EPI) monitoring the C-C phenol coupling of 4′-O-methylnorbelladine and
4′-O-methyl-N-methylnorbelladine in CYP96T1 assays. Arrows indicate peaks unique to Sf9 cell containing assays with substrate present. (A) Standards and
assays with 4′-O-methylnorbelladine as the substrate. Sample runs top to bottom (10bR,4aS)- and (10bS,4aR)-noroxomaritidine standard (1µM), CYP96T1 assay,
CPR assay, assay without Sf9 cells, and CYP96T1 assay without 4′-O-methylnorbelladine. (B) Standards and assays with 4′-O-methyl-N-methylnorbelladine as the
substrate. Top to bottom narwedine standard, CYP96T1 assay, CPR assay, assay without Sf9 cells, and assay without 4′-O-methylnorbelladine. (C) EPI of the
(10bR,4aS)- and (10bS,4aR)-noroxomaritidine standard. (D) EPI of the CYP96T1 (10bR,4aS)- and (10bS,4aR)-noroxomaritidine product with 4′-O-methylnorbelladine
as substrate. (E) EPI of the CYP96T1 para-para’ product (Unknown 1) with 4′-O-methyl-N-methylnorbelladine as substrate. Red fragments indicate the addition of
one methyl group, 14 m/z, relative to (10bR,4aS)- and (10bS,4aR)-noroxomaritidine and blue fragments indicate the same m/z as (10bR,4aS)- and
(10bS,4aR)-noroxomaritidine fragments. Intensity is presented in counts per second (CPS).
173.7 ± 140.0µM respectively. No substrate inhibition was
observed in (R)-coclaurine or (S)-coclaurine with concentrations
up to 1000µM. The kcat of 4
′-O-methylnorbelladine was
higher than observed for 4′-O-methyl-N-methylnorbelladine,
(R)-coclaurine, or (S)-coclaurine. The kcat/Km value 4
′-
O-methylnorbelladine is at least one order of magnitude
larger than the 4′-O-methyl-N-methylnorbelladine, (R)-
coclaurine, or (S)-coclaurine values consistent with the role of
4′-O-methylnorbelladine as the native substrate.
Some cytochrome P450 enzymes generate reactive H2O2
when lacking a substrate (Mishin et al., 2014). To confirm
H2O2 generation by CYP96T1 was not the mechanism of
action for C-C phenol coupling, the effects of H2O2 addition
and catalase mediated H2O2 removal on C-C phenol coupling
of 4′-O-methylnorbelladine were examined. This was done by
adding all combinations of H2O2 and/or the H2O2-consuming
enzyme catalase to CPR negative controls or CYP96T1 functional
assays. The addition of 0.1% H2O2 to assays was found
to enhance approximately 10-fold the production of the
4′-O-methylnorbelladine C-C phenol coupling in the CPR
control, but no enhancement was observed in a functioning
CYP96T1 assay. Although product formation resulted from
H2O2 in CPR controls, the CYP96T1 assays produced ∼100-
fold more product than these control assays. The addition
of 0.1mg/ml catalase to the assays reversed the effects of
supplemented H2O2 on CPR control assays, but did not reduce
the level of product observed in the CYP96T1 assays, indicating
that H2O2 is not involved in enzymatic phenol couple formation.
Sodium Borohydride Assays and Analysis
by LC-MS/MS
Enzymatically formed N-demethylnarwedine from enzyme
assays with CYP96T1 was converted toN-demethylgalanthamine
by sodium borohydride reduction and detected by LC-MS/MS
(Figure 8A). Sodium borohydride selectively reduced the ketone
group on (10bS,4aR)- and (10bR,4aS)-noroxomaritidine and
N-demethylnarwedine to yield a stereoisomeric mixture
of the corresponding alcohols 8-O-demethylmaritidine
and N-demethylgalanthamine. Confirmation of N-
demethylgalanthamine in these assays is demonstrated by
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FIGURE 6 | Chromatographic separation and MS/MS analysis of the primary 4′-O-methylnorbelladine products (10bS,4aR)- and
(10bR,4aS)-noroxomaritidine. The enantiomers (10bS,4aR)- and (10bR,4aS)-noroxomaritidine were chromatographically separated with a chiral-CBH column and
analyzed by MS/MS using an enhanced product ion (EPI) scan. (A) Samples, top to bottom: (10bR,4aS)- and (10bS,4aR)-noroxomaritidine standard, CYP96T1 assay,
CPR assay, CYP96T1 assay without 4′-O-methylnorbelladine substrate and no Sf9 cells assay. (B) EPI fragmentation pattern for enantiomer 1 of (10bR,4aS)- and
(10bS,4aR)-noroxomaritidine. (C) EPI fragmentation pattern for enantiomer 2 of (10bR,4aS)- and (10bS,4aR)-noroxomaritidine. (D) EPI fragmentation pattern for
enantiomer 1 in the CYP96T1 assay with 4′-O-methylnorbelladine as substrate. (E) EPI fragmentation pattern for enantiomer 2 in the CYP96T1 assay with
4′-O-methylnorbelladine as substrate. Intensity is presented in counts per second (CPS).
the identical retention time (Figure 8A) and fragmentation
pattern (Figures 8B,C) with N-demethylgalanthamine standard.
Another peak is also present with a different retention time
(Figure 8A) and very similar fragmentation pattern (Figure 8D)
and is likely the diastereomer epi-N-demethylgalanthamine
formed by non-stereospecific ketone reduction. Stereoisomeric
8-O-demethylmaritidine is present in sodium borohydride
reduced CYP96T1 4′-O-methylnorbelladine assays as the largest
product peak (Figure 8A). This is validated by a comparison
of the LC-MS/MS fragmentation pattern of (10bS,4aR)- and
(10bR,4aS)-noroxomaritidine reduced by sodium borohydride
to the corresponding peak in the CYP96T1 assay (Figures 8E,F).
To examine the potential relevance of the minor enzymatic
product N-demethylnarwedine to galanthamine production in
N. sp. aff. pseudonarcissus, flowering plants were collected and
the scales of three bulbs were examined for haemanthamine and
galanthamine content. As a result, haemanthamine was found
to be 2.23 ± 0.38mg/g fresh weight and galanthamine levels
0.246 ± 0.021 mg/g fresh weight. This translates into an 8.62-
fold molar haemanthamine to galanthamine ratio. This prevalent
ratio of haemanthamine relative to galanthamine in planta could
indicate a higher significance of contribution of the CYP96T1 N-
demethylnarwedine product to galanthamine biosynthesis than
is at first evident from the ratio of enzymatically formed phenol-
coupled products in vitro.
DISCUSSION
CYP96T1 converts 4′-O-methylnorbelladine to the products
(10bS,4aR)- and (10bR,4aS)-noroxomaritidine indicating that
this enzyme is involved in the biosynthesis of (10bR,4aS)-
noroxomaritidine-derived alkaloids such as haemanthamine.
Because (10bS,4aR)-noroxomaritidine derivatives have not been
previously reported from Narcissus spp., the enantiomeric
mixture of (10bS,4aR)- and (10bR,4aS)-noroxomaritidine made
by CYP96T1 is interesting. One possibility is that the enzyme
accepts 4′-O-methylnorbelladine in the two conformations
required to make the two enantiomers. The enzyme subsequently
would catalyze the phenol-phenol coupling and may still be
bound to the intermediate upon nitrogen ring closure. This
would, however, lead to an altered position of the 4′-O-methyl
group in the active site and would likely lead to a preference
for one conformation over the other. Since this preference is
not observed, a second possibility that the CYP96T1 enzyme is
only making the achiral intermediate that later spontaneously
forms the different enantiomeric forms of noroxomaritidine is
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FIGURE 7 | Relative product formed in assays with 4′-O-methylnorbelladine (A,B) or 4′-O-methyl-N-methylnorbelladine (C,D,E) as substrate. Assays
are performed in triplicate only expressing CPR or with CPR in combination with CYP96T1. (A) para-para’ [(10bR,4aS)- and (10bS,4aR)-noroxomaritidine] product. (B)
para-ortho’ (N-demethylnarwedine) product. (C) Potentially para-para’ C-C phenol coupling (unknown 1) product. (D) para-ortho’ (Narwedine) product. (E) Potentially
ortho-para’ C-C phenol coupling (unknown 2) product.
TABLE 5 | Substrate specificity tests for CYP96T1.
Substrate Km (µM) kcat (1/min) kcat/Km (1/µM*min) Ki Modifications monitored
4′-O-Methylnorbelladine 1.13 ± 0.54 15.0 ± 2.03 13 64.3 ± 26.40 C-C phenol coupling
4′-O-Methyl-N-methylnorbelladine 3.28 ± 2.27 2.44 ± 0.54 0.742 174 ± 140 C-C phenol coupling
(S)-Coclaurine 637 ± 156 1.34 ± 0.15 2.11× 10−3 NA Intramolecular phenol coupling and
Intermolecular coupling
(R)-Coclaurine 659 ± 104 2.07 ± 0.14 3.15× 10−3 NA Intramolecular phenol coupling and
Intermolecular coupling
3′-O-Methylnorbelladine NA ND NA NA C-C phenol coupling
3′,4′-O-Dimethylnorbelladine NA ND NA NA C-C phenol coupling
Norbelladine NA ND NA NA C-C phenol coupling
N-Methylnorbelladine NA ND NA NA C-C phenol coupling
Haemanthamine NA ND NA NA Methoxy bridge formation and hydroxylation
(10bS,4aR)- and (10bR,4aS)-Noroxomaritidine NA ND NA NA Methoxy bridge formation and hydroxylation
Isovanillin and tyramine NA ND NA NA C-C phenol coupling, amine-aldehyde
condensation, amine-aldehyde condensation,
and C-C phenol coupling
ND, not detected; NA, not applicable.
more likely. If the second possibility is the case, the absence of
(10bS,4aR)-noroxomaritidine derivatives in Narcissus spp. may
result from another enzyme perhaps associated with CYP96T1
directing the chirality of the ring closure, or in either case
(10bS,4aR)-noroxomaritidine could be subject to degradation.
The production of N-demethylnarwedine by CYP96T1 is of
interest to galanthamine biosynthesis. The low amount produced
relative to (10bS,4aR)- and (10bR,4aS)-noroxomaritidine
indicates that under the assay conditions used N-
demethylnarwedine is not the enzyme’s primary product. Kinetic
analysis shows a clear preference for 4′-O-methylnorbelladine
over all other tested substrates (Table 5).
A diradical mechanism has been proposed for formation of
the C-C phenol coupled product of (R)-reticuline and 4′-O-
methylnorbelladine (Eichhorn et al., 1998; Grobe et al., 2009)
(Figures 9A,B). A radical is formed on a hydroxyl group ortho
or para to the position for formation of a carbon bond.
To determine if the 3′ (para’) hydroxyl group is important
to C-C phenol coupling, 3′-O-methylnorbelladine and 3′,4′-O-
dimethylnorbelladine were tested for enzymatic activity; product
formation was not observed. The lack of activity with a methoxy
group at the para’ position indicates that a free hydroxyl
moiety is important at this position to enable extraction of
a hydroxyl radical by the enzyme (Figure 9A). These results
support the proposed mechanism for C-C phenol coupling of
4′-O-methylnorbelladine.
The oxygen binding and activation motif (A/G)GX(D/E)TT
is substantially different between CYP96T1 (and its variants)
when compared to cytochrome P450 enzymes that catalyze
hydroxylation reactions. The substitutions G322Q, D324N, and
T326Q replace key hydrophobic, acidic, and alcoholic groups
with neutral hydrophilic amide groups. This is consistent with
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FIGURE 8 | LC-MS/MS Enhanced Product Ion (EPI) scan of sodium borohydride (NaBH4) treated CYP96T1 assays with 4
′-O-methylnorbelladine
substrate. (A) Chromatograph with the following sample runs top to bottom: N-demethylgalanthamine standard, CYP96T1 assay, CPR assay, assay with no Sf9 cells
and CYP96T1 assay without 4’-O-methylnorbelladine. (B) EPI fragmentation pattern of the N-demethylgalanthamine standard peak eluting at 4min. (C) EPI
fragmentation pattern of the N-demethylgalanthamine product in the CYP96T1 assay. (D) EPI fragmentation pattern of epi-N-demethylgalanthamine from the
CYP96T1 assay. (E) EPI fragmentation pattern of (10bS,4aR)- and (10bR,4aS)-noroxomaritidine standard reduced to stereoisomeric 8-O-demethylmaritidine. (F) EPI
fragmentation pattern of reduced (10bS,4aR)- and (10bR,4aS)-noroxomaritidine product from CYP96T1 assays.
the proposal ofMizutani and Sato that cytochrome P450 enzymes
not performing hydroxylation reactions can have a significantly
altered oxygen binding and activation site (Mizutani and Sato,
2011). The highly conserved (387-389) EXXR, PERF (430-433)
PXRX, and heme binding (464-473) FXXGXRXCXG motifs are
present (Syed and Mashele, 2014). These motifs are thought
to have more universal functions than substrate hydroxylation
including maintenance of proper structural integrity and heme
placement in cytochrome P450 enzymes (Hasemann et al., 1995;
Hatae et al., 1996).
Presented herein is the first documented C-C phenol coupling
cytochrome P450 enzyme in monocots. It is in the CYP96
family of cytochrome P450 enzymes, which falls into the CYP86
clan. The CYP96A15 from A. thaliana has been previously
documented to be a midchain alkane hydroxylase involved
in wax synthesis (Greer et al., 2007). Previously documented
members of the CYP86 clan have shown activity toward fatty
alcohols, fatty acids, alkanes, and derivatives thereof (Nelson
and Werck-Reichhart, 2011). This makes this phenolic alkaloid
a novel substrate class for this clan of cytochrome P450
enzymes. All other documented C-C phenol coupling plant
cytochrome P450 enzymes are in the CYP71 clan (Nelson
and Werck-Reichhart, 2011). This indicates the C-C phenol
coupling activity of CYP96T1 was acquired independently
from other known C-C phenol coupling cytochrome P450
enzymes. This independent origin of C-C phenol coupling
could help direct the search for new C-C phenol coupling
cytochrome P450 enzymes. The independent evolution of
CYP96T1 shows that future searches for novel C-C phenol
coupling enzymes should look broadly across the cytochrome
P450 families because lineages of cytochrome P450 enzymes
responsible for these reaction activities have likely not all been
identified. Other phenol-phenol coupling reactions potentially
performed by cytochrome P450s include the intramolecular
coupling of 4′-O-methylnorbelladine to oxonorpluvine in
lycorine biosynthesis, (S)-autumnaline to isoandrocymbine in
colchicine biosynthesis, and the intermolecular C-C phenol
coupling of dioncophylline A biosynthesis (Bringmann et al.,
2000; Herbert, 2003).
When searching for additional phenol coupling enzymes
responsible for the biosynthesis of the galanthamine and
lycorine skeletons, the untested cytochrome P450 homologs
co-expressing withN4OMT are prime candidates. TheseN4OMT
co-expressing transcripts could also encode the hydroxylases or
oxide bridge forming enzymes found in haemanthamine and
lycorine biosynthesis.
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FIGURE 9 | Proposed C-C phenol coupling mechanisms. (A) 4′-O-methylnorbelladine para-para’ C-C phenol coupling mechanism followed by spontaneous
nitrogen ring closure to form noroxomaritidine. (B) (R)-reticuline para-ortho’ C-C phenol coupling mechanism to form salutaridine panel adapted from Grobe et al.
(2009).
AUTHOR CONTRIBUTIONS
MK contributed to the study planning, performed most
experiments, and wrote most of the manuscript. MA performed
the isolation of RNA for sequencing and contributed to the
writing of the manuscript. GM, JC performed the sequencing
and subsequent transcriptome assemblies for Galanthus spp. and
provided feedback on the manuscript. TK acquired funding for
the study, conceived the study, and contributed to the writing
of the manuscript. All authors approved the final version of the
manuscript.
FUNDING
This work was supported by the National Institutes of Health
award number 1RC2GM092561 (NIGMS). This material is based
upon work supported by the National Science Foundation under
Grant No. DBI-0521250 for acquisition of the QTRAP LC-
MS/MS.
ACKNOWLEDGMENTS
G. elwesii collection and identification was done thanks
to Laurence Davin from Washington State University.
Thank you to J. Steen Hoyer for critiquing this
manuscript.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fpls.2016.
00225
Frontiers in Plant Science | www.frontiersin.org 14 February 2016 | Volume 7 | Article 225
Kilgore et al. Identification and Characterization of CYP96T1
REFERENCES
Barik, J., Dajas-Bailador, F., and Wonnacott, S. (2005). Cellular responses
to nicotinic receptor activation are decreased after prolonged exposure to
galantamine in human neuroblastoma cells. Br. J. Pharmacol. 145, 1084–1092.
doi: 10.1038/sj.bjp.0706278
Barton, D. H. R., Kirby, G. W., Taylor, J. B., and Thomas, G. M.
(1961). The biosynthesis of Amaryllidaceae alkaloids. Proc. Chem. Soc.
254–255.
Barton, D. H. R., Kirby, G. W., and Thomas, G. M. (1963). Phenol oxidation and
biosynthesis. Part VI. The biogenesis of Amaryllidaceae alkaloids. J. Chem. Soc.
1963, 4545–4558. doi: 10.1039/jr9630004545
Battersby, A. R., Bink, R., and Breuer, S. W. (1961a). Biosynthesis in the
Amaryllidaceae: incorporation of norbelladine into lycorine and norpluvine.
Proc. Chem. Soc. 243.
Battersby, A. R., and Binks, R. (1960). Biosynthesis of lycorine. Proc. Chem. Soc.
410–411.
Battersby, A. R., Binks, R., Breuer, S. W., Fales, H. M., Wildman, W. C., and
Highet, R. J. (1964). Alkaloid biosynthesis. Part III.* Amaryllidaceae alkaloids:
the biosynthesis of lycorine and its relatives. J. Chem. Soc. 1595–1609. doi:
10.1039/jr9640001595
Battersby, A. R., Fales, H. M., and Wildman, W. C. (1961b). Biosynthesis in the
Amaryllidaceae. Tyrosine and norbelladine as precursors of haemanthamine. J.
Am. Chem. Soc. 83, 4098–4099. doi: 10.1021/ja01480a037
Belin, P., Le Du, M. H., Fielding, A., Lequin, O., Jacquet, M., Charbonnier, J. B.,
et al. (2009). Identification and structural basis of the reaction catalyzed by
CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis. Proc.
Natl. Acad. Sci. U.S.A. 106, 7426–7431. doi: 10.1073/pnas.0812191106
Bringmann, G., Wohlfarth, M., Rischer, H., Grüne, M., and Schlauer, J. (2000).
A New Biosynthetic Pathway to Alkaloids in Plants: Acetogenic Isoquinolines.
Angew. Chem. Int. Ed. Engl. 39, 1464–1466. doi: 10.1002/(SICI)1521-
3773(20000417)39:83.0.CO;2-#
Cheesman, L., Nair, J. J., and Van Staden, J. (2012). Antibacterial activity of crinane
alkaloids from Boophone disticha (Amaryllidaceae). J. Ethnopharmacol. 140,
405–408. doi: 10.1016/j.jep.2012.01.037
Constantin, M. A., Conrad, J., and Beifuss, U. (2012). Laccase-catalyzed oxidative
phenolic coupling of vanillidene derivatives. Green Chem. 14, 2375–2379. doi:
10.1039/c2gc35848d
Davin, L. B., Jourdes, M., Patten, A. M., Kim, K. W., Vassão, D. G., and Lewis,
N. G. (2008). Dissection of lignin macromolecular configuration and assembly:
comparison to related biochemical processes in allyl/propenyl phenol and
lignan biosynthesis. Nat. Prod. Rep. 25, 1015–1090. doi: 10.1039/b510386j
Edgar, R. C. (2004). MUSCLE: multiple sequence alignment with high
accuracy and high throughput. Nucleic Acids Res. 32, 1792–1797. doi:
10.1093/nar/gkh340
Eichhorn, J., Takada, T., Kita, Y., and Zenk, M. H. (1998). Biosynthesis of
the amaryllidaceae alkaloid galanthamine. Phytochemistry 49, 1037–1047. doi:
10.1016/S0031-9422(97)01024-8
Feinstein, A. I., and Wildman, W. C. (1976). Biosynthetic oxidation and
rearrangement of vittatine and its derivatives. J. Org. Chem. 41, 2447–2450. doi:
10.1021/jo00876a020
Fuganti, C., Staunton, J., and Battersby, A. R. (1971). The biosynthesis
of narciclasine. J. Chem. Soc. Chem. Commun. 19, 1154–1155. doi:
10.1039/c29710001154
Gesell, A., Rolf, M., Ziegler, J., Díaz Chávez,M. L., Huang, F. C., and Kutchan, T.M.
(2009). CYP719B1 is salutaridine synthase, the C-C phenol-coupling enzyme of
morphine biosynthesis in opium poppy. J. Biol. Chem. 284, 24432–24442. doi:
10.1074/jbc.M109.033373
Greer, S., Wen, M., Bird, D., Wu, X., Samuels, L., Kunst, L., et al. (2007). The
cytochrome P450 enzyme CYP96A15 is the midchain alkane hydroxylase
responsible for formation of secondary alcohols and ketones in stem cuticular
wax of Arabidopsis. Plant Physiol. 145, 653–667. doi: 10.1104/pp.107.107300
Grobe, N., Zhang, B., Fisinger, U., Kutchan, T. M., Zenk, M. H., and Guengerich, F.
P. (2009). Mammalian cytochrome P450 enzymes catalyze the phenol-coupling
step in endogenous morphine biosynthesis. J. Biol. Chem. 284, 24425–24431.
doi: 10.1074/jbc.M109.011320
Haas, B. J., Papanicolaou, A., Yassour, M., Grabherr, M., Blood, P. D., Bowden,
J., et al. (2013). De novo transcript sequence reconstruction from RNA-seq
using the Trinity platform for reference generation and analysis. Nat. Protoc.
8, 1494–1512. doi: 10.1038/nprot.2013.084
Hasemann, C. A., Kurumbail, R. G., Boddupalli, S. S., Peterson, J. A., and
Deisenhofer, J. (1995). Structure and function of cytochromes P450: a
comparative analysis of three crystal structures. Structure 3, 41–62. doi:
10.1016/S0969-2126(01)00134-4
Hatae, T., Hara, S., Yokoyama, C., Yabuki, T., Inoue, H., Ullrich, V., et al. (1996).
Site-directed mutagenesis of human prostacyclin synthase: alteration of Cys441
of the Cys-pocket, and Glu347 and Arg350 of the EXXR motif. FEBS Lett. 389,
268–272. doi: 10.1016/0014-5793(96)00600-X
Havelek, R., Seifrtova, M., Kralovec, K., Bruckova, L., Cahlikova, L., Dalecka,
M., et al. (2014). The effect of Amaryllidaceae alkaloids haemanthamine
and haemanthidine on cell cycle progression and apoptosis in p53-
negative human leukemic Jurkat cells. Phytomedicine 21, 479–490. doi:
10.1016/j.phymed.2013.09.005
Herbert, R. B. (2003). The biosynthesis of plant alkaloids and nitrogenous
microbial metabolites. Nat. Prod. Rep. 20, 494–508. doi: 10.1039/b006522f
Ikezawa, N., Iwasa, K., and Sato, F. (2008). Molecular cloning and characterization
of CYP80G2, a cytochrome P450 that catalyzes an intramolecular C-C phenol
coupling of (S)-reticuline in magnoflorine biosynthesis, from cultured Coptis
japonica cells. J. Biol. Chem. 283, 8810–8821. doi: 10.1074/jbc.M705082200
Irwin, R. L., and Smith, H. J. (1960). Cholinesterase inhibition by galanthamine
and lycoramine. Biochem. Pharmacol. 3, 147–148. doi: 10.1016/0006-
2952(60)90030-7
Iseli, C., Jongeneel, C. V., and Bucher, P. (1999). ESTScan: a program for detecting,
evaluating, and reconstructing potential coding regions in EST sequences. Proc.
Int. Conf. Intell. Syst. Mol. Biol. 1999, 138–148.
Jeffs, P. (1962). The Alkaloids of the Amaryllidaceae. Part X.* Biosynthesis of
haemanthamine. Proc. Chem. Soc. 80–81.
Kilgore, M. B., Augustin, M. M., Starks, C. M., O’Neil-Johnson, M., May, G.
D., Crow, J. A., et al. (2014). Cloning and characterization of a norbelladine
4′-O-methyltransferase involved in the biosynthesis of the Alzheimer’s drug
galanthamine in Narcissus sp. aff. pseudonarcissus. PLoS ONE 9:e103223. doi:
10.1371/journal.pone.0103223
Lehmann, T., and Pollmann, S. (2009). Gene expression and characterization of
a stress-induced tyrosine decarboxylase from Arabidopsis thaliana. FEBS Lett.
583, 1895–1900. doi: 10.1016/j.febslet.2009.05.017
Li, Y., Liu, J., Tang, L. J., Shi, Y. W., Ren, W., and Hu, W. X. (2007). Apoptosis
induced by lycorine in KM3 cells is associated with the G0/G1 cell cycle arrest.
Oncol. Rep. 17, 377–384. doi: 10.3892/or.17.2.377
Liu, J., Hu, W. X., He, L. F., Ye, M., and Li, Y. (2004). Effects of lycorine on HL-60
cells via arresting cell cycle and inducing apoptosis. FEBS Lett. 578, 245–250.
doi: 10.1016/j.febslet.2004.10.095
Liu, X. S., Jiang, J., Jiao, X. Y., Wu, Y. E., Lin, J. H., and Cai, Y. M. (2009).
Lycorine induces apoptosis and down-regulation of Mcl-1 in human leukemia
cells. Cancer Lett. 274, 16–24. doi: 10.1016/j.canlet.2008.08.029
Mann, J. D. (1963). Alkaloids and plant metabolism. VI. O-Methylation in vitro
of norbelladine, a precursor of Amaryllidaceae alkaloids. J. Biol. Chem. 238,
3820–3823.
Mishin, V., Heck, D. E., Laskin, D. L., and Laskin, J. D. (2014). Human
recombinant cytochrome P450 enzymes display distinct hydrogen peroxide
generating activities during substrate independent NADPH oxidase reactions.
Toxicol. Sci. 141, 344–352. doi: 10.1093/toxsci/kfu133
Mizutani, M., and Sato, F. (2011). Unusual P450 reactions in plant
secondary metabolism. Arch Biochem. Biophys. 507, 194–203. doi:
10.1016/j.abb.2010.09.026
Mockler, T. C., Michael, T. P., Priest, H. D., Shen, R., Sullivan, C. M., Givan, S.
A., et al. (2007). The DIURNAL project: DIURNAL and circadian expression
profiling, model-based pattern matching, and promoter analysis. Cold Spring
Harb. Symp. Quant. Biol. 72, 353–363. doi: 10.1101/sqb.2007.72.006
Nelson, D., and Werck-Reichhart, D. (2011). A P450-centric view of plant
evolution. Plant J. 66, 194–211. doi: 10.1111/j.1365-313X.2011.04529.x
Oloyede, G. K., Oke, J. M., Raji, Y., and Olugbade, T. A. (2010). Antioxidant and
anticonvulsant alkaloids in Crinum ornatum Bulb Extract. World J. Chem. 5,
26–31.
Park, J. B. (2014). Synthesis and characterization of norbelladine, a precursor
of Amaryllidaceae alkaloid, as an anti-inflammatory/anti-COX compound.
Bioorg. Med. Chem. Lett. 24, 5381–5384. doi: 10.1016/j.bmcl.2014.10.051
Frontiers in Plant Science | www.frontiersin.org 15 February 2016 | Volume 7 | Article 225
Kilgore et al. Identification and Characterization of CYP96T1
Ruiz-Olalla, A., Würdemann, M. A.,Wanner, M. J., Ingemann, S., vanMaarseveen,
J. H., andHiemstra, H. (2015). Organocatalytic enantioselective pictet–spengler
approach to biologically relevant 1-benzyl-1,2,3,4-tetrahydroisoquinoline
alkaloids. J. Org. Chem. 80, 5125–5132. doi: 10.1021/acs.joc.
5b00509
Schlauer, J., Rückert, M., Wiesen, B., Herderich, M., Assi, L. A., Haller, R. D., et al.
(1998). Characterization of enzymes from Ancistrocladus (Ancistrocladaceae)
and Triphyophyllum (Dioncophyllaceae) catalyzing oxidative coupling of
naphthylisoquinoline alkaloids to michellamines. Arch. Biochem. Biophys. 350,
87–94. doi: 10.1006/abbi.1997.0494
Suhadolnik, R. J., Fischer, A. G., and Zulalian, J. (1963). Biogenesis of the
Amaryllidaceae alkaloids. II. Studies with whole plants, floral primordia and cell
free extracts. Biochem. Biophys. Res. Commun. 11, 208–212. doi: 10.1016/0006-
291X(63)90335-8
Syed, K., and Mashele, S. S. (2014). Comparative analysis of P450
signature motifs EXXR and CXG in the large and diverse kingdom
of fungi: identification of evolutionarily conserved amino acid patterns
characteristic of P450 family. PLoS ONE 9:e95616. doi: 10.1371/journal.pone.
0095616
Teitel, S., and Brossi, A. (1968). An improved synthesis of various racemic
polyphenolic tetrahydroisoquinoline alkaloids. J. Heterocycl. Chem. 5, 825–829.
doi: 10.1002/jhet.5570050614
Van Goietsenoven, G., Andolfi, A., Lallemand, B., Cimmino, A., Lamoral-
Theys, D., Gras, T., et al. (2010). Amaryllidaceae alkaloids belonging
to different structural subgroups display activity against apoptosis-
resistant cancer cells. J. Nat. Prod. 73, 1223–1227. doi: 10.1021/np90
08255
Wilcock, G., Howe, I., Coles, H., Lilienfeld, S., Truyen, L., Zhu, Y., et al. (2003).
A long-term comparison of galantamine and donepezil in the treatment
of Alzheimer’s disease. Drugs Aging 20, 777–789. doi: 10.2165/00002512-
200320100-00006
Wildman,W. C., and Bailey, D. T. (1969). Amaryllidaceae interconversions. Partial
synthesis of [2]benzopyran[3,4c]indoles. J. Am. Chem. Soc. 91, 150–157. doi:
10.1021/ja01029a030
Wildman, W. C., Battersby, A. R., and Breuer, S. W. (1962a). Biosynthesis in the
Amaryllidaceae. Incorporation of 3-C14-tyrosine and phenylalanine in Nerine
bowdeniiW.Wats. J. Am. Chem. Soc. 84, 4599–4600. doi: 10.1021/ja00882a051
Wildman, W. C., Fales, H. M., and Battersby, A. R. (1962b). Biosynthesis in the
Amaryllidaceae. The incorporation of 3-C14-tyrosine in Sprekelia formosissima.
J. Am. Chem. Soc. 84, 681–682. doi: 10.1021/ja00863a042
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
A patent application has been filed for the sequences of CYP96T1-3.
Copyright © 2016 Kilgore, Augustin, May, Crow and Kutchan. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Plant Science | www.frontiersin.org 16 February 2016 | Volume 7 | Article 225
